rezpegaldesleukin
Showing 1 - 1 of 1
Moderate to Severe Atopic Dermatitis Trial in United States (Rezpegaldesleukin, Placebo)
Recruiting
- Moderate to Severe Atopic Dermatitis
- Rezpegaldesleukin
- Placebo
-
Los Angeles, California
- +4 more
Nov 13, 2023